ArticleExpert systems with applications2021
#stayhome to contain Covid-19: Neuro-SIR - Neurodynamical epidemic modeling of infection patterns in social networks.
Article in Expert systems with applications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Emergence of complex oscillatory dynamics in the neuronal networks with long activity time of inhibitory synapses.iScience · 2024Article
- Analysis of SIRVI model with time dependent coefficients and the effect of vaccination on the transmission rate and COVID-19 epidemic waves.Infectious Disease Modelling · 2023Article
- Study on the virulence evolution of SARS-CoV-2 and the trend of the epidemics of COVID-19.Mathematical methods in the applied sciences · 2022Article
- An extended epidemic model with vaccination: Weak-immune SIRVI.Physica A · 2022Article
- Who are the 'silent spreaders'?: contact tracing in spatio-temporal memory models.Neural computing & applications · 2022Article
- Article
- Controlling the Outbreak of COVID-19: A Noncooperative Game Perspective.IEEE access : practical innovations, open solutions · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An innovative neurodynamical model of epidemics in social networks - the Neuro-SIR - is introduced. Susceptible-Infected-Removed (SIR) epidemic processes are mechanistically modeled as analogous to the activity propagation in neuronal populations. The workings of infection transmission from individual to individual through a network of social contacts, is driven by the dynamics of the threshold mechanism of leaky integrate-and-fire neurons. Through this approach a dynamically evolving landscape of the susceptibility of a population to a disease is formed. In this context, epidemics with varying velocities and scales are triggered by a small fraction of infected individuals according to the configuration of various endogenous and exogenous factors representing the individuals' vulnerability, the infectiousness of a pathogen, the density of a contact network, and environmental conditions. Adjustments in the length of immunity (if any) after recovery, enable the modeling of the Susceptible-Infected-Recovered-Susceptible (SIRS) process of recurrent epidemics. Neuro-SIR by supporting an impressive level of heterogeneities in the description of a population, contagiousness of a disease, and external factors, allows a more insightful investigation of epidemic spreading in comparison with existing approaches. Through simulation experiments with Neuro-SIR, we demonstrate the effectiveness of the #stayhome strategy for containing Covid-19, and successfully validate the simulation results against the classical epidemiological theory. Neuro-SIR is applicable in designing and assessing prevention and control strategies for spreading diseases, as well as in predicting the evolution pattern of epidemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.